tiprankstipranks
Trending News
More News >
ChemoMetec A/S (GB:0DZ0)
LSE:0DZ0
UK Market

ChemoMetec A/S (0DZ0) Financial Statements

Compare
0 Followers

ChemoMetec A/S Financial Overview

ChemoMetec A/S's market cap is currently €8.11B. The company's EPS TTM is kr9.715; its P/E ratio is 48.95; and it has a dividend yield of 0.84%. ChemoMetec A/S is scheduled to report earnings on February 5, 2025, and the estimated EPS forecast is kr3.47. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Jun 21Jun 20Jun 19Jun 18
Income Statement
Total Revenue
Gross Profit$ 384.25M$ 253.34M$ 193.92M$ 158.62M$ 99.47M
Operating Income$ 202.76M$ 116.85M$ 77.18M$ 54.03M$ 24.28M
EBITDA$ 224.86M$ 133.26M$ 92.55M$ 65.29M$ 29.75M
Net Income$ 159.47M$ 88.35M$ 59.16M$ 41.84M$ 18.21M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 501.27M$ 344.91M$ 263.12M$ 238.22M$ 114.00M
Total Debt$ 6.79M$ 2.36M$ 2.29M$ 18.80M$ 20.11M
Net Debt$ -202.23M$ -147.75M$ -94.65M$ -79.40M$ 10.33M
Total Liabilities$ 144.07M$ 79.93M$ 60.37M$ 64.87M$ 40.98M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ 120.94M$ 83.28M$ 45.28M$ 31.24M$ 8.97M
Operating Cash Flow$ 176.86M$ 107.90M$ 72.02M$ 58.31M$ 25.44M
Investing Cash Flow
Financing Cash Flow
Currency in USD

ChemoMetec A/S Earnings and Revenue History

ChemoMetec A/S Debt to Assets

ChemoMetec A/S Cash Flow

ChemoMetec A/S Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis